Microbot Medical Inc. Files 8-K on Shareholder Rights and Bylaws
Ticker: MBOT · Form: 8-K · Filed: Apr 15, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, bylaws, shareholder-rights
TL;DR
Microbot Medical filed an 8-K on 4/15 detailing changes to shareholder rights and bylaws, effective 4/14.
AI Summary
Microbot Medical Inc. filed an 8-K on April 15, 2025, reporting material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. The filing also covers shareholder nominations and financial exhibits, with the earliest event reported on April 14, 2025. The company, formerly known as STEMCELLS INC and CYTOTHERAPEUTICS INC/DE, is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing indicates potential changes in corporate governance or shareholder rights, which could impact the company's strategic direction and investor relations.
Risk Assessment
Risk Level: medium — Changes to rights of security holders and bylaws can signal significant corporate events or governance shifts that may affect stock value.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- STEMCELLS INC (company) — Former Company Name
- CYTOTHERAPEUTICS INC/DE (company) — Former Company Name
- April 14, 2025 (date) — Earliest event reported
- April 15, 2025 (date) — Filing Date
FAQ
What specific material modifications were made to the rights of security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the provided text excerpt.
What amendments were made to Microbot Medical Inc.'s articles of incorporation or bylaws?
The filing states that there were amendments to the articles of incorporation or bylaws, but the specific nature of these amendments is not detailed in the excerpt.
What is the significance of the 'Shareholder Nominations Pursuant to Exchange Act Rule 14a-11' item?
This item indicates that the filing includes information related to shareholder nominations for director positions, as governed by SEC Rule 14a-11.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 14, 2025.
What were Microbot Medical Inc.'s former company names?
Microbot Medical Inc. was formerly known as STEMCELLS INC and CYTOTHERAPEUTICS INC/DE.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Microbot Medical Inc. (MBOT).